Patent: 7,393,994
✉ Email this page to a colleague
Summary for Patent: 7,393,994
Title: | Transgenic mouse model for neurodegenerative diseases |
Abstract: | Alzheimer\'s disease, Parkinson\'s disease and Lewy body disease are the most commonly found neurodegenerative disorders in the elderly. The invention is a transgenic mouse that contains two transgenes, human .alpha.-synuclein and human amyloid precursor protein, which are responsible for the formation of the neuritic plaques, Lewy bodies and neurodegeneration seen in the above mentioned diseases. The transgenic mouse is an accurate model for disease by both functional and pathological assays. |
Inventor(s): | Masliah; Eliezer (San Diego, CA), Rockenstein; Edward (Chula Vista, CA), Mallory; Margaret E. (Encinitas, CA) |
Assignee: | Regents of the University of California (Oakland, CA) |
Application Number: | 09/933,640 |
Patent Claims: | see list of patent claims |
Details for Patent 7,393,994
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2020-02-18 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2020-02-18 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2020-02-18 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |